Chemkart India Limited IPO
Chemkart India Limited is a Mumbai-based nutraceutical company offering a diverse range of nutritional, health, and sports supplement products. Positioned as a one-stop B2B solution, Chemkart primarily supplies ingredients to manufacturers of finished supplements such as vitamins, proteins, health and sports supplements.
Business Model
Chemkart targets the B2B segment, building long-term relationships with health supplement manufacturers. The company specializes in amino acids and operates under seven major product categories: Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins.
Product Portfolio
The company provides ingredients essential for formulating finished health and dietary supplements. Major processed raw materials include:
i) L-Leucine Instant
ii) L-Isoleucine
iii) L-Valine
iii) L-Lysine HCL
iii) DL-Methionine
These materials are processed into blends and powders through in-house blending and grinding facilities to suit customer-specific needs.
Geographical Presence
Chemkart India Limited generates a significant share of its revenue from Maharashtra, Gujarat, and Delhi—contributing approximately 77.71% in FY23, 66.55% in FY24, and 56.97% in FY25. While the company’s current international sales are limited, it aims to gradually expand its footprint into global markets.
Competitive Strengths
i) Diversified Product Portfolio across 7 categories
ii) In-House Processing Capabilities with advanced blending and grinding units
iii) Strong B2B Relationships ensuring consistent repeat business
iv) Quality Assurance through third-party verified standards
Future Outlook
Chemkart aims to expand its reach beyond its core markets and increase its presence in global nutraceutical trade. With its scalable infrastructure and diverse product offerings, the company is well-positioned to tap into growing health-conscious consumer trends globally.
Objects of the Chemkart India Limited IPO:
Chemkart India Limited IPO Details:
Open Date: | Jul 07 2025 |
Close Date: | Jul 09 2025 |
Total Shares: | 32,29,200 |
Face Value: | ₹ 10 Per Equity Share |
Issue Type: | Book Building |
Issue Size: | 80.08 Cr. |
Lot Size: | 600 Shares |
Issue Price: | ₹ 236 to 248 Per Equity Share |
Listing At: | BSE SME |
Promoters And Management:
Financials of Chemkart India Limited IPO:
Particulars | FY 2024-25 | FY 2023-2024 | FY 2022-2023 |
Revenue from Operations | 203.27 | 132.02 | 131.37 |
EBITDA | 32.76 | 20.91 | 11.04 |
EBITDA Margins | 16.12% | 15.84% | 8.41% |
PAT | 24.25 | 14.52 | 7.66 |
PAT Margins | 12.00% | 11.00% | 6.00% |
ROCE | 49.00% | 51.00% | 43.00% |
Debt to Equity Ratio(In Times) | 0.32 | 0.43 | 0.78 |
Operating Cash Flows | 3.96 | -0.023 | 0.059 |
Comparison With Peers:
Lead Manager of Chemkart India Limited IPO:
Registrar of Chemkart India Limited IPO:
Discussion on Chemkart India Limited IPO:
Leave a Reply
You must be logged in to post a comment.